These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37859316)

  • 1. Liver Metabolomics Analysis Revealing Key Metabolites Associated with Different Stages of Nonalcoholic Fatty Liver Disease in Hamsters.
    Gao SS; Shen YL; Chen YW; Wei XZ; Hu JJ; Wang J; Wu WJ
    Comb Chem High Throughput Screen; 2024; 27(9):1303-1317. PubMed ID: 37859316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and metabonomics analysis of nonalcoholic fatty liver disease model in golden hamster.
    Zhao CZ; Jiang L; Li WY; Wu G; Chen J; Dong LH; Li M; Jiang W; Zhu JX; Gao YP; Ma QG; Zhong GY; Wei RR
    Z Naturforsch C J Biosci; 2022 May; 77(5-6):197-206. PubMed ID: 35286786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabonomics Application on Screening Serum Biomarkers of Golden Hamsters with Nonalcoholic Steatohepatitis Induced by High-Fat Diet.
    Hu J; Shen Y; Chen Y
    Comb Chem High Throughput Screen; 2023; 26(13):2280-2292. PubMed ID: 36815651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
    Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X
    Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of ApoA5 aggravates spontaneous and diet-induced nonalcoholic fatty liver disease by reducing hepatic NR1D1 in hamsters.
    Guo J; Miao G; Zhang W; Shi H; Lai P; Xu Y; Zhang L; Chen G; Han Y; Zhao Y; Liu G; Zhang L; Wang Y; Huang W; Xian X
    Theranostics; 2024; 14(5):2036-2057. PubMed ID: 38505614
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of celastrol on autophagy and endoplasmic reticulum stress-mediated apoptosis in a mouse model of nonalcoholic fatty liver disease].
    Tian T; Liao XC; Zhang M; Wu XM; Guo YT; Tan SY
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):656-662. PubMed ID: 36038329
    [No Abstract]   [Full Text] [Related]  

  • 7. Dietary Supplementation with Hazelnut Oil Reduces Serum Hyperlipidemia and Ameliorates the Progression of Nonalcoholic Fatty Liver Disease in Hamsters Fed a High-Cholesterol Diet.
    Lu JH; Hsia K; Lin CH; Chen CC; Yang HY; Lin MH
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31540081
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intervention of Catalpol on High-fat Diet Induced Nonalcoholic Fatty Liver Disease in Mice].
    Tian X; Xiong Q; Chen L; Wen JR; Ru Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):746-755. PubMed ID: 31907123
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
    Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the Hepatoprotection of
    Feng Y; Li H; Chen C; Lin H; Xu G; Li H; Wang C; Chen J; Sun J
    Front Pharmacol; 2021; 12():727636. PubMed ID: 34621168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
    J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease.
    Zhang J; Li S; Li J; Han C; Wang Z; Li C; Wang X; Liu Z; Wen J; Zheng L
    Chin Med J (Engl); 2014; 127(21):3771-6. PubMed ID: 25382334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untargeted metabolomics reveals the role of AQP9 in nonalcoholic fatty liver disease in a mice model.
    Cheng Q; Zhang J; Fang J; Ding H; Xu Y; Lu X; Zhang W
    Int J Biol Macromol; 2022 Oct; 219():864-875. PubMed ID: 35961555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
    Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W
    J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin Capsules improves high fat diet-induced nonalcoholic fatty liver disease in hamsters through modifying hepatic de novo lipogenesis and fatty acid oxidation.
    Cui CX; Deng JN; Yan L; Liu YY; Fan JY; Mu HN; Sun HY; Wang YH; Han JY
    J Ethnopharmacol; 2017 Aug; 208():24-35. PubMed ID: 28648927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.
    McGlinchey AJ; Govaere O; Geng D; Ratziu V; Allison M; Bousier J; Petta S; de Oliviera C; Bugianesi E; Schattenberg JM; Daly AK; Hyötyläinen T; Anstee QM; Orešič M
    JHEP Rep; 2022 May; 4(5):100477. PubMed ID: 35434590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome.
    Sogabe M; Okahisa T; Kurihara T; Takehara M; Kagemoto K; Okazaki J; Kida Y; Hirao A; Tanaka H; Tomonari T; Taniguchi T; Okamoto K; Nakasono M; Takayama T
    PLoS One; 2020; 15(8):e0238388. PubMed ID: 32866186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet.
    Svop Jensen V; Fledelius C; Max Wulff E; Lykkesfeldt J; Hvid H
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33673227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gynostemma pentaphyllum saponins alleviate non-alcoholic fatty liver disease in rats by regulating intestinal flora and short-chain fatty acid metabolism].
    Zhong FW; Li GX; Zeng L
    Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2500-2508. PubMed ID: 35531697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of pharmacodynamics and metabolomics to reveal rhubarb anthraquinone protection against nonalcoholic fatty liver disease rat model.
    Zhang F; Wu R; Liu Y; Dai S; Gong X; Li Y
    J Pharm Pharmacol; 2024 Apr; 76(4):381-390. PubMed ID: 38349666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.